 | • レポートコード：D0FB0631587 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥420,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥532,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 組換え治療用抗体及びタンパク質のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は組換え治療用抗体及びタンパク質の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける組換え治療用抗体及びタンパク質市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・組換え治療用抗体及びタンパク質のアジア市場規模推移2014-2019 ・組換え治療用抗体及びタンパク質のアジア市場規模予測2019-2024 ・組換え治療用抗体及びタンパク質のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Abbott、Amgen、Biogen、Eli Lilly、Roche、Johnson and Johnson、Merck、Novo Nordisk、Pfizer、Sanofi） ・結論 |
Abstract:
The Asia Pacific Recombinant Therapeutic Antibodies and Proteins market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific Recombinant Therapeutic Antibodies and Proteins market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Recombinant Therapeutic Antibodies and Proteins market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Recombinant Therapeutic Antibodies and Proteins
* It describes present situation, historical background and future forecast
* Comprehensive data showing Recombinant Therapeutic Antibodies and Proteins capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Recombinant Therapeutic Antibodies and Proteins manufacturers
* Recombinant Therapeutic Antibodies and Proteins market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific Recombinant Therapeutic Antibodies and Proteins market: (At least 10 companies included)
* Abbott
* Amgen
* Biogen
* Eli Lilly
* Roche
* Johnson and Johnson
For complete list, please ask for sample pages.
The Recombinant Therapeutic Antibodies and Proteins market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis Recombinant Therapeutic Antibodies and Proteins market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis Recombinant Therapeutic Antibodies and Proteins market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One Recombinant Therapeutic Antibodies and Proteins Overview
1.1 Recombinant Therapeutic Antibodies and Proteins Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of Recombinant Therapeutic Antibodies and Proteins Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of Recombinant Therapeutic Antibodies and Proteins (2014-2019)
4.1 Recombinant Therapeutic Antibodies and Proteins Supply
4.2 Recombinant Therapeutic Antibodies and Proteins Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Recombinant Therapeutic Antibodies and Proteins Supply
5.2 Recombinant Therapeutic Antibodies and Proteins Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific Recombinant Therapeutic Antibodies and Proteins Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Abbott
8.2 Amgen
8.3 Biogen
8.4 Eli Lilly
8.5 Roche
……
……
Chapter Nine Research Conclusions of Asia Pacific Recombinant Therapeutic Antibodies and Proteins Industry
Tables and Figures
Figure Commercial Product of Recombinant Therapeutic Antibodies and Proteins
Table Classification of Recombinant Therapeutic Antibodies and Proteins
Table Application of Recombinant Therapeutic Antibodies and Proteins
Figure Porter Five Forces Model Analysis of Asia Pacific Recombinant Therapeutic Antibodies and Proteins
Figure Production Cost Analysis of Asia Pacific Recombinant Therapeutic Antibodies and Proteins
Table Recombinant Therapeutic Antibodies and Proteins Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity List
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production List
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Production Value and Growth Rate
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Recombinant Therapeutic Antibodies and Proteins
Table 2014-2019 Asia Pacific Import and Export of Recombinant Therapeutic Antibodies and Proteins
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand List by Application
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand by Application
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand Share List by Application
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand Share by Application
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption Share
Table 2014-2019 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity List
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production List
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Recombinant Therapeutic Antibodies and Proteins
Table 2019-2024 Asia Pacific Import and Export of Recombinant Therapeutic Antibodies and Proteins
Table 2019-2024 Asia Pacific Demand of Recombinant Therapeutic Antibodies and Proteins by Application
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand by Application
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand Share List by Application
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Demand Share by Application
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption List
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Country-wise Consumption Share
Table 2019-2024 Asia Pacific Recombinant Therapeutic Antibodies and Proteins Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Recombinant Therapeutic Antibodies and Proteins Raw Material Suppliers
Table Key End Users List
Table Profile of Abbott
Table SWOT Analysis of Abbott
Table Abbott Recombinant Therapeutic Antibodies and Proteins Product Specification
Table 2014-2019 Abbott Recombinant Therapeutic Antibodies and Proteins Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Abbott Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2014-2019 Abbott Recombinant Therapeutic Antibodies and Proteins Production Global Market Share
Table SWOT Analysis of Amgen
Figure Amgen Recombinant Therapeutic Antibodies and Proteins Products
Table 2014-2019 Amgen Recombinant Therapeutic Antibodies and Proteins Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Amgen Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2014-2019 Amgen Recombinant Therapeutic Antibodies and Proteins Production Global Market Share
Table SWOT Analysis of Biogen
Figure Biogen Recombinant Therapeutic Antibodies and Proteins Product
Table Biogen Recombinant Therapeutic Antibodies and Proteins Product Specification
Table 2014-2019 Biogen Recombinant Therapeutic Antibodies and Proteins Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biogen Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2014-2019 Biogen Recombinant Therapeutic Antibodies and Proteins Production Global Market Share
Table Profile of Eli Lilly
Table SWOT Analysis of Eli Lilly
Figure Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product
Table Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product Specification
Table 2014-2019 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2014-2019 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Production Global Market Share
Table Profile of Roche
Table SWOT Analysis of Roche
Figure Roche Recombinant Therapeutic Antibodies and Proteins Product
Table 2014-2019 Roche Recombinant Therapeutic Antibodies and Proteins Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Roche Recombinant Therapeutic Antibodies and Proteins Capacity Production and Growth Rate
Figure 2014-2019 Roche Recombinant Therapeutic Antibodies and Proteins Production Global Market Share
……
……
組換えタンパク質のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Recombinant Proteins market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on …- 血友病A及びB組換え因子補充療法のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Hemophilia A And B Recombinant Factor Replacement Therapy market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for w…
- 神経科抗体及びアッセイのアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Neuroscience Antibodies and Assays market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed i…
- 小麦タンパク質（小麦グルテン）のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Wheat Proteins(wheat gluten) market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informa…
- 発酵タンパク質のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Fermented Proteins market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on As…